We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Use the filters or search function to help find relevant consultations.
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (82)
- Legislation (15)
- Committees and advisory bodies (12)
- Manufacturing (9)
- Labelling and packaging (8)
- Safety monitoring and information (5)
- Fees and payments (4)
- Sunscreens (4)
- Advertising (3)
- Import and export (3)
- Shortages and supply disruptions (3)
- Medicinal cannabis hub (2)
- Clinical trials (1)
- Compliance and enforcement (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Search
274 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on the regulation of radiopharmaceuticals in Australia. These medicines contain small amounts of radioactive material, used to support the diagnosis and treatment of serious conditions, including cancer and cardiovascular disease.
-
ConsultationWe are seeking feedback on proposed changes to publishing information about Good Manufacturing Practice (GMP) compliance on our website.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
ConsultationWe are seeking feedback on proposed changes to improve the regulation of therapeutic sunscreens in Australia.
-
ConsultationWe are reviewing our rules for personalised medical devices to make sure they keep pace with new technology and continue to be used safely.
-
ConsultationWe want your feedback on the proposed changes to the Conformity Assessment procedures for medical devices.
-
ConsultationWe are seeking feedback on proposed changes to Australian medicine labelling rules. The consultation end date has been extended to 23 March 2026.
-
ConsultationWe have opened a consultation to provide industry and other interested stakeholders with an opportunity to comment on the our proposed updates to the ACE Scheme Compliance Program
-
ConsultationWe have opened a consultation on our proposed fees and charges for the 2026-27 financial year.
-
ConsultationWe are seeking feedback on proposed amendments relating to transparency of disruptions to supply of a medical device.
-
ConsultationWe are seeking input from stakeholders responsible for developing, deploying or supplying Digital Mental Health Tools (DMHT) to help us better understand these tools.
-
ConsultationWe need your help to understand how Digital Mental Health Tools (DMHT) are being accessed and used by Australians.
-
ConsultationWe are seeking feedback on whether certain international scientific guidelines should be adopted
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
ConsultationThe Therapeutic Goods Administration (TGA) is inviting industry feedback on proposed regulatory changes to ensure the legislation governing medicinal maggots is fit-for-purpose.
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking feedback on potential changes to the Therapeutic Goods Regulations 1990 applying to manufacturing of certain bacteriophage therapy products (BTPs) in Australia.
-
ConsultationWe are seeking industry feedback on proposed amendments to strengthen the legal framework governing TMFs for blood and blood components, and PMFs for Type II plasma-derived products.
-
ConsultationWe are seeking feedback on the current usage of paper information included with injectable medicines.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
ConsultationWe are seeking stakeholder input on their experiences, observations and knowledge of the use of unapproved medicinal cannabis products to inform our considerations for future regulatory reform.
-
ConsultationIn accordance with regulation 42ZCZK of the Therapeutic Goods Regulations 1990, the Secretary invites public submissions on scheduling proposals referred to the June 2025 meetings of the Advisory Committees on Medicines and Chemicals Scheduling.
-
ConsultationWe are seeking feedback on whether we should adopt 3 international scientific guidelines.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS)
-
ConsultationWe are seeking stakeholders’ feedback on proposed changes to the IVD medical device classifications and definitions.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the
Advisory Committee on Medicines Scheduling (ACMS), or a joint meeting of the ACMS and Advisory Committee on Chemicals Scheduling (ACCS)